TERN
Price:
$8.27
Market Cap:
$698.29M
Terns Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis (NASH) and obesity. The company develops TERN-101, a liver-distributed and non-bile acid farnesoid X receptor agonist, which is in Phase IIa clinical trial for the treatment of NASH; and TERN-201, a vascular adhesion protein-1 inhibitor that is in Phase Ib clinical trial for the treatment of NASH. It also develops TERN-501, a thyroid hormone receptor beta agonist with enhanced liver distribution and metabolic stability that is in Phase I clinical trial for the treatment of NASH; and TERN-601, a smal...[Read more]
Industry
Biotechnology
IPO Date
2021-02-05
Stock Exchange
NASDAQ
Ticker
TERN
According to Terns Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 607.04M. This represents a change of 52.22% compared to the average of 398.79M of the last 4 quarters.
The mean historical Enterprise Value of Terns Pharmaceuticals, Inc. over the last ten years is 324.41M. The current 607.04M Enterprise Value has changed 18.61% with respect to the historical average. Over the past ten years (40 quarters), TERN's Enterprise Value was at its highest in in the March 2023 quarter at 642.86M. The Enterprise Value was at its lowest in in the June 2020 quarter at 0.
Average
324.41M
Median
370.73M
Minimum
130.95M
Maximum
449.20M
Discovering the peaks and valleys of Terns Pharmaceuticals, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 71.65%
Maximum Annual Enterprise Value = 449.20M
Minimum Annual Increase = -67.27%
Minimum Annual Enterprise Value = 130.95M
Year | Enterprise Value | Change |
---|---|---|
2023 | 383.15M | 70.45% |
2022 | 224.79M | 71.65% |
2021 | 130.95M | -67.27% |
2020 | 400.08M | -10.94% |
2019 | 449.20M | 25.36% |
The current Enterprise Value of Terns Pharmaceuticals, Inc. (TERN) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
246.30M
5-year avg
317.63M
10-year avg
324.41M
Terns Pharmaceuticals, Inc.’s Enterprise Value is greater than Amylyx Pharmaceuticals, Inc. (140.56M), greater than Acumen Pharmaceuticals, Inc. (102.65M), greater than Inozyme Pharma, Inc. (355.81M), greater than X4 Pharmaceuticals, Inc. (35.68M), greater than Mereo BioPharma Group plc (595.29M), greater than PDS Biotechnology Corporation (103.25M), greater than HOOKIPA Pharma Inc. (64.03M), less than Day One Biopharmaceuticals, Inc. (998.00M), greater than Eledon Pharmaceuticals, Inc. (78.51M),
Company | Enterprise Value | Market cap |
---|---|---|
140.56M | $212.42M | |
102.65M | $142.39M | |
355.81M | $324.34M | |
35.68M | $104.67M | |
595.29M | $676.56M | |
103.25M | $136.60M | |
64.03M | $136.28M | |
998.00M | $1.24B | |
78.51M | $103.90M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Terns Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Terns Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Terns Pharmaceuticals, Inc.'s Enterprise Value?
What is the highest Enterprise Value for Terns Pharmaceuticals, Inc. (TERN)?
What is the 3-year average Enterprise Value for Terns Pharmaceuticals, Inc. (TERN)?
What is the 5-year average Enterprise Value for Terns Pharmaceuticals, Inc. (TERN)?
How does the current Enterprise Value for Terns Pharmaceuticals, Inc. (TERN) compare to its historical average?